Janssen Turns To High Court In Bid To Block Zytiga Generics
Janssen Biotech Inc. said on Tuesday it was going to sprint to the U.S. Supreme Court after the Federal Circuit refused to block sales of generic versions of Zytiga while Janssen...To view the full article, register now.
Already a subscriber? Click here to view full article